Microbio Co., Ltd. (4128.TWO)
TWD 33.6
(-2.33%)
TWD 33.6
(-2.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -78.14 Million | 141.56 Million | 53.98 Million | 109.81 Million | 72.35 Million | 15.84 Million |
| Net Income | -1.17 Billion | 151.82 Million | -231.86 Million | 519.42 Million | -255 Million | -727.61 Million |
| Depreciation & Amortization | 245.16 Million | 242.48 Million | 270.2 Million | 212.11 Million | 190.1 Million | 63.04 Million |
| Deferred income taxes | -387.12 Million | - | -704.36 Million | -1.61 Billion | - | 632.82 Million |
| Stock-based compensation | 395 Thousand | 109 Thousand | 820.6 Million | 932.6 Million | - | 40.31 Million |
| Change in working capital | 50.63 Million | 5.59 Million | 115.43 Million | 101.87 Million | -50.81 Million | 45.51 Million |
| Other non-cash items | 1.19 Billion | -258.44 Million | -216.02 Million | -42.85 Million | 188.07 Million | -38.23 Million |
| Investing Cash Flow | -258.7 Million | 334.55 Million | 19.8 Million | -591.58 Million | -712.01 Million | -528.97 Million |
| Investments in PPE | -48.04 Million | -43.12 Million | -103.96 Million | -79.83 Million | -292.35 Million | -296.56 Million |
| Acquisitions | 3.74 Million | -40.89 Million | -202.5 Million | -50.32 Million | 123.85 Million | 128.7 Million |
| Investment purchases | -1.9 Billion | -1.8 Billion | -43.44 Million | -470.33 Million | -428.16 Million | -97.34 Million |
| Sales/Maturities of investments | 1.69 Billion | 2.16 Billion | 208.94 Million | 3.75 Million | -123.85 Million | 4 Million |
| Other Investing Activities | -2.67 Million | 59.36 Million | 160.76 Million | 5.14 Million | 8.5 Million | -267.77 Million |
| Financing Cash Flow | -155.98 Million | -67.11 Million | -42.19 Million | -172.89 Million | -338.46 Million | 1.73 Billion |
| Debt repayment | -283 Thousand | -723 Thousand | -998 Thousand | -123.75 Million | -25.24 Million | -353 Million |
| Dividends payments | -20.44 Million | -18.65 Million | - | - | - | - |
| Common Stock Repurchased | - | -723 Thousand | - | -142.46 Million | -299.62 Million | -8.31 Million |
| Common Stock Issuance | - | 94.15 Million | 108.87 Million | 236.93 Million | -299.62 Million | - |
| Other Financing Activities | -135.25 Million | -141.17 Million | -150.06 Million | -9.57 Million | 585.65 Million | 2.1 Billion |
| Accounts receivables | 46.79 Million | -9.48 Million | -11.44 Million | 4.38 Million | -1.52 Million | -13.27 Million |
| Accounts payables | 44.05 Million | -7.38 Million | 10.92 Million | -1.75 Million | -27.77 Million | 664 Thousand |
| Inventory | 12.75 Million | -5.89 Million | -6.08 Million | -8.52 Million | 24.38 Million | 23.37 Million |
| Other working capital | -52.96 Million | 28.35 Million | 122.03 Million | 107.76 Million | -45.9 Million | 22.14 Million |
| Cash at beginning of period | 1.15 Billion | 725.7 Million | 679.66 Million | 1.3 Billion | 2.37 Billion | 1.17 Billion |
| Cash at end of period | 635.8 Million | 1.13 Billion | 725.7 Million | 679.66 Million | 1.3 Billion | 2.37 Billion |
| Capital Expenditure | -48.04 Million | -43.12 Million | -103.96 Million | -79.83 Million | -292.35 Million | -296.56 Million |
| Effect of forex changes on cash | -22.2 Million | -2.64 Million | 14.44 Million | 33.16 Million | -97.15 Million | -24.25 Million |
| Net cash flow / Change in cash | -515.28 Million | 406.36 Million | 46.04 Million | -621.49 Million | -1.07 Billion | 1.2 Billion |
| Free Cash Flow | -126.18 Million | 98.44 Million | -49.98 Million | 29.98 Million | -219.99 Million | -280.71 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -153.13 Million | -240.04 Million | -83.59 Million | -1.17 Billion | -566.28 Million | -549.53 Million |
| Depreciation & Amortization | 66.07 Million | 64.82 Million | 63.76 Million | 245.16 Million | 60.67 Million | 60.43 Million |
| Deferred income taxes | - | - | -107.77 Million | -387.12 Million | 495.06 Million | 420.59 Million |
| Stock-based compensation | 75 Thousand | 88 Thousand | 94 Thousand | 395 Thousand | 103 Thousand | 97 Thousand |
| Change in working capital | 36.08 Million | -51.07 Million | -19 Million | 50.63 Million | 94.25 Million | 23.79 Million |
| Other non-cash items | 150.38 Million | 192.21 Million | 98.45 Million | 1.19 Billion | -20.45 Million | -21.04 Million |
| Investing Cash Flow | 11.76 Million | 69.28 Million | 33.37 Million | -258.7 Million | 133.17 Million | 62.54 Million |
| Investments in PPE | -6.98 Million | -15.06 Million | -23.92 Million | -48.04 Million | -4.82 Million | -5.77 Million |
| Acquisitions | -1000.00 | 54 Thousand | 3.67 Million | 3.74 Million | 46.07 Million | -26 Thousand |
| Investment purchases | -153.85 Million | -260.97 Million | -512.13 Million | -1.9 Billion | -589.34 Million | -186.88 Million |
| Sales/Maturities of investments | 171.65 Million | 346.46 Million | 569.48 Million | 1.69 Billion | 681.1 Million | 252.65 Million |
| Other Investing Activities | 940 Thousand | -1.19 Million | -3.72 Million | -2.67 Million | 157 Thousand | 2.56 Million |
| Financing Cash Flow | -38.74 Million | -35.55 Million | -49.21 Million | -155.98 Million | -36.08 Million | -32.91 Million |
| Debt repayment | -501 Thousand | -506 Thousand | -1.18 Million | -283 Thousand | -474 Thousand | -525 Thousand |
| Dividends payments | - | - | -20.44 Million | -20.44 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -38.24 Million | -2.43 Million | -27.58 Million | -135.25 Million | -35.61 Million | -32.38 Million |
| Accounts receivables | 6.94 Million | 3.05 Million | 24.7 Million | 46.79 Million | -1.1 Million | -3.02 Million |
| Accounts payables | -22.9 Million | -4.75 Million | 17.47 Million | 44.05 Million | 56.24 Million | -18.23 Million |
| Inventory | 14.15 Million | -8.39 Million | -22.32 Million | 12.75 Million | 8.3 Million | 18.09 Million |
| Other working capital | 37.89 Million | -40.47 Million | -38.85 Million | -52.96 Million | 30.81 Million | 26.96 Million |
| Cash at beginning of period | 617.57 Million | 635.8 Million | 714.46 Million | 1.15 Billion | 545.51 Million | 582.05 Million |
| Cash at end of period | 552.35 Million | 601.39 Million | 635.8 Million | 635.8 Million | 701.27 Million | 545.51 Million |
| Capital Expenditure | -6.98 Million | -15.06 Million | -23.92 Million | -48.04 Million | -4.82 Million | -5.77 Million |
| Effect of forex changes on cash | 406 Thousand | -1.55 Million | -20.34 Million | -22.2 Million | -4.68 Million | -519 Thousand |
| Net cash flow / Change in cash | -65.21 Million | -34.41 Million | -78.65 Million | -515.28 Million | 155.75 Million | -36.54 Million |
| Free Cash Flow | -41.51 Million | -62.88 Million | -71.98 Million | -126.18 Million | 58.52 Million | -71.42 Million |
BOROLTD
001696
MKKOF
1454
6762
0RG5